Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Naltrexone Implant in Opioid-Dependent Patients After Detoxification
CTR20181954Phase 2Completed
- Sponsor
- Hunan Saiwo Pharmaceutical
- Start
- Nov 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of naltrexone implant in opioid use disorder (OUD), sponsored by Hunan Saiwo Pharmaceutical. Started Nov 2018; status: completed.
02
Drugs
naltrexone implant
03
Conditions
opioid use disorder (OUD)
Beyond the preview
Go deeper on CTR20181954.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20181954.